| Symbol | HCWB |
|---|---|
| Name | HCW BIOLOGICS INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 2929 N COMMERCE PARKWAY, MIRAMAR, Florida, 33025, United States |
| Telephone | +1 954 842-2024 |
| Fax | — |
| — | |
| Website | https://www.hcwbiologics.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001828673 |
| Description | HCW Biologics Inc is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company believes age-related low-grade chronic inflammation is a significant contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases. Additional info from NASDAQ: |
New Form EFFECT - HCW Biologics Inc. <b>Filed:</b> 2026-06-18 <b>AccNo:</b> 9999999995-26-002066 <b>Size:</b> 1 KB
Read moreNew Form S-1/A - HCW Biologics Inc. <b>Filed:</b> 2026-06-18 <b>AccNo:</b> 0001493152-26-029235 <b>Size:</b> 248 KB
Read more(90% Positive) HCW BIOLOGICS INC. (HCWB) Announces Clinical Development Update
Read moreHCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata
Read moreNew Form D - HCW Biologics Inc. <b>Filed:</b> 2026-06-08 <b>AccNo:</b> 0001828673-26-000003 <b>Size:</b> 10 KB
Read moreNew Form S-1 - HCW Biologics Inc. <b>Filed:</b> 2026-06-08 <b>AccNo:</b> 0001493152-26-027656 <b>Size:</b> 898 KB
Read moreDirector Wong Hing C 🟢 acquired 227.8K shares (1 derivative) of HCW Biologics Inc. (HCWB) at $1.41 Transaction Date: May 22, 2026 | Filing ID: 025478
Read moreDirector GARRETT SCOTT T 🟢 acquired 355.9K shares (1 derivative) of HCW Biologics Inc. (HCWB) at $1.41 Transaction Date: May 22, 2026 | Filing ID: 025476
Read more